Viemed Healthcare
VMD
77 hedge funds and large institutions have $161M invested in Viemed Healthcare in 2021 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 30 increasing their positions, 26 reducing their positions, and 31 closing their positions.
15% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 26
3.35% more ownership
Funds ownership: 53.43% → 56.78% (+3.4%)
23% less funds holding
Funds holding: 100 → 77 (-23)
25% less capital invested
Capital invested by funds: $214M → $161M (-$53.1M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
74% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 31
Top Buyers
Top Sellers
VMD Hedge Fund Activity: Q2 2021 in Review
77 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Viemed Healthcare (VMD) for Q2 2021, worth a combined $161M — down 25% from $214M a quarter earlier.
Sellers outnumbered buyers: 31 funds closed out of VMD and 8 opened new positions — a net loss of 23 holders — while 26 trimmed existing stakes and 30 added.
The largest buyer was Thrivent Financial for Lutherans, adding an estimated $15.3M. The largest seller was Wellington Management Group, exiting entirely with an estimated $2.35M sold.
- 77 institutional investors held Viemed Healthcare (VMD) as of Q2 2021, down from 100 in Q1 2021.
- Funds reported $161M of Viemed Healthcare stock for Q2 2021, down 25% quarter-over-quarter.
- 8 funds opened new Viemed Healthcare positions in Q2 2021 and 31 closed out, a net change of -23 holders.
- The largest Viemed Healthcare buyer in Q2 2021 was Thrivent Financial for Lutherans, an estimated $15.3M added.
- The largest Viemed Healthcare seller in Q2 2021 was Wellington Management Group, an estimated $2.35M sold.
Based on aggregated 13F filings for Q2 2021.